株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

神経修復・再生の世界市場の予測 〜2022年:治療法(神経縫合術・神経移植術、幹細胞治療、神経刺激術)、製品(生体材料、神経管、神経プロテクター、神経ラップ、神経刺激装置)、地域別

Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 281743
出版日 ページ情報 英文 124 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
神経修復・再生の世界市場の予測 〜2022年:治療法(神経縫合術・神経移植術、幹細胞治療、神経刺激術)、製品(生体材料、神経管、神経プロテクター、神経ラップ、神経刺激装置)、地域別 Nerve Repair and Regeneration Market by Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation Surgery), Products (Biomaterials, Nerve Conduits, Nerve Protectors, Nerve Wraps, Neurostimulation Devices) - Global Forecast to 2022
出版日: 2017年11月10日 ページ情報: 英文 124 Pages
概要

世界の神経修復・再生市場の規模は2017年から2022年にかけて12.9%の複合年間成長率(CAGR)で推移し、2017年には57億9000万米ドルに、2022年までに105億9000万米ドル規模に拡大することが見込まれています。神経損傷事例の増加や、高齢化の進行に伴う神経疾患の増加などが当市場の主な促進要因となっています。

当レポートでは、世界の神経修復・再生市場について調査し、市場の概要、治療法・製品・地域別の市場動向、市場規模の推移と予測、市場成長への各種影響要因の分析、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 神経修復・再生市場の概要
  • アジアの神経修復・再生市場:用途・国別
  • 神経修復・再生市場:地域別の概要
  • 神経移植市場:タイプ別

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
      • 神経損傷事例の増加
      • 高齢化の進行に伴う神経疾患の増加
      • 技術的進歩
    • 阻害要因
      • 神経修復・再建療法より好まれる医薬品による治療
      • 専門家の不足
    • 市場機会
      • 新興市場
      • 神経修復・再生術における幹細胞治療の潜在性
    • 課題
      • 生体ドナーの合併症
      • 厳しい規制と承認までの長い道のり

第6章 神経修復・再生の世界市場:製品別

  • イントロダクション
  • 神経刺激・神経調整装置
    • 内部神経刺激装置
      • 脊髄刺激
      • 深部脳刺激
      • 迷走神経刺激
      • 仙骨神経刺激
      • 胃電気刺激
    • 外部神経刺激装置
      • 経皮電気神経刺激
      • 経頭蓋磁気刺激
  • 生体材料
    • 神経管
    • 神経プロテクター
    • 神経ラップ
    • 神経コネクター

第7章 神経修復・再生の世界市場:治療法別

  • イントロダクション
  • 神経刺激・神経調節手術
    • 内部
    • 外部
  • 直接神経修復・神経縫合術
    • 神経上膜修復
    • 神経周囲修復
    • グループ神経束修復
  • 神経移植術
    • 自家移植
    • 同種移植
    • 異種移植
  • 幹細胞治療

第8章 神経修復・再生の世界市場:エンドユーザー別

  • イントロダクション
  • 病院・診療所
  • 外来外科センター

第9章 神経修復・再生の世界市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア
  • その他

第10章 競合環境

  • イントロダクション
  • 市場シェアの分析
  • 競合情勢・動向
    • 規制・承認
    • 合併・買収
    • 新製品の発表
    • 合意・提携・協力

第11章 企業プロファイル

  • AXOGEN
  • BAXTER
  • BOSTON SCIENTIFIC
  • LIVANOVA
  • INTEGRA LIFESCIENCES
  • MEDTRONIC
  • ABBOTT LABORATORIES
  • STRYKER
  • POLYGANICS
  • NUVECTRA
  • NEUROPACE
  • ORTHOMED
  • NEVRO

第12章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3642

The nerve repair and regeneration market is expected to reach USD 10.59 million by 2022 from USD 5.79 billion in 2017, at a CAGR of 12.9%. Factors such as increasing number of neurological disorders, technological advancements, and rising geriatric population are driving the growth of this market. On the other hand, donor-site morbidity, difficulties in treating large nerve gaps, and stringent regulatory frameworks and time-consuming approval processes may challenge the growth of the market.

Neurostimulation and neuromodulation devices segment is expected to account for the largest share in the market

On the basis of product, the nerve repair and regeneration market is segmented into neurostimulation and neuromodulation devices and biomaterials. In 2017, the neurostimulation and neuromodulation devices segment is expected to account for the largest share of this market segment. This growth can be attributed to the increasing neurological disorders and favorable reimbursement policies.

Internal neurostimulation and neuromodulation surgeries segment is expected to register the highest CAGR during the forecast period

Based on application, the nerve repair and regeneration market is segmented into into internal neurostimulation and neuromodulation surgeries and external neurostimulation and neuromodulation surgeries. The internal neurostimulation and neuromodulation surgeries segment is expected to register highest growth rate during the forecast period. This growth can be attributed to its wide application in neurological disorders.

North America is expected to account for the largest regional segment in the market

Geographically, the nerve repair and regeneration market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017 and the trend is expected to continue during the forecast period. The growth in this market can be attributed to the presence of major key players in the region and growing incidence of peripheral nerve injuries.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1 - 35%, Tier 2 - 22% and Tier 3 - 43%
  • By Designation - C level - 15%, Director level - 32%, Others - 53%
  • By Region - North America - 32%, Europe - 27%, Asia - 22%, RoW - 19%

Key players operating in the nerve repair and regeneration market include Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), LivaNova (UK), Baxter (US), AxoGen (US), and Stryker (US).

Study Coverage:

The report analyses the nerve repair and regeneration market by product, applications, end user, and regions. Apart from comprehensive geographic and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the report profiles companies with developments, and strategies adopted by key players to maintain and increase their shares in the market. The above-mentioned market research data, market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.

Benefits of Buying the Report:

This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.

The report provides insights on the following strategies:

  • Market Penetration: The report analyzes the nerve repair and regeneration market by product, application, and end user
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the nerve repair and regeneration market
  • Market Development: Comprehensive information about emerging markets. This report analyzes the market for various nerve repair and regeneration product across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the nerve repair and regeneration market.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. RESEARCH ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. NERVE REPAIR AND REGENERATION: MARKET OVERVIEW
  • 4.2. ASIAN NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION AND COUNTRY
  • 4.3. GEOGRAPHIC SNAPSHOT OF THE NERVE REPAIR AND REGENERATION MARKET
  • 4.4. NERVE GRAFTING MARKET, BY TYPE

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. High incidence of nerve injuries
      • 5.2.1.2. Rising geriatric population and subsequent growth in the prevalence of neurological disorders
      • 5.2.1.3. Technological advancements
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Greater preference for drug therapies over nerve repair and regeneration products
      • 5.2.2.2. Dearth of trained professionals
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Potential of stem cell therapy in nerve repair and regeneration
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Donor-site morbidity
      • 5.2.4.2. Difficulties in treating large nerve gaps
      • 5.2.4.3. Stringent regulatory frameworks and time-consuming approval processes

6. NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. NEUROSTIMULATION AND NEUROMODULATION DEVICES
    • 6.2.1. INTERNAL NEUROSTIMULATION DEVICES
      • 6.2.1.1. Spinal cord stimulation
      • 6.2.1.2. Deep brain stimulation
      • 6.2.1.3. Vagus nerve stimulation
      • 6.2.1.4. Sacral nerve stimulation
      • 6.2.1.5. Gastric electrical stimulation
    • 6.2.2. EXTERNAL NEUROSTIMULATION DEVICES
      • 6.2.2.1. Transcutaneous electrical nerve stimulation
      • 6.2.2.2. Transcranial magnetic stimulation
  • 6.3. BIOMATERIALS
    • 6.3.1. NERVE CONDUITS
    • 6.3.2. NERVE PROTECTORS
    • 6.3.3. NERVE WRAPS
    • 6.3.4. NERVE CONNECTORS

7. NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. NEUROSTIMULATION AND NEUROMODULATION SURGERIES
    • 7.2.1. INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES
    • 7.2.2. EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES
  • 7.3. DIRECT NERVE REPAIR/NEURORRHAPHY
    • 7.3.1. EPINEURAL REPAIR
    • 7.3.2. PERINEURAL REPAIR
    • 7.3.3. GROUP FASCICULAR REPAIR
  • 7.4. NERVE GRAFTING
    • 7.4.1. AUTOGRAFTS
    • 7.4.2. ALLOGRAFTS
    • 7.4.3. XENOGRAFTS
  • 7.5. STEM CELL THERAPY

8. NERVE REPAIR AND REGENERATION MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS & CLINICS
  • 8.3. AMBULATORY SURGERY CENTERS

9. NERVE REPAIR AND REGENERATION MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
  • 9.4. ASIA
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. INTRODUCTION
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SITUATION AND TRENDS
    • 10.3.1. REGULATORY APPROVALS
    • 10.3.2. MERGERS AND ACQUISITIONS
    • 10.3.3. PRODUCT LAUNCHES
    • 10.3.4. AGREEMENTS, COLLABORATION AND PARTNERSHIPS

11. COMPANY PROFILES (Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*

  • 11.1. AXOGEN
  • 11.2. BAXTER
  • 11.3. BOSTON SCIENTIFIC
  • 11.4. LIVANOVA
  • 11.5. INTEGRA LIFESCIENCES
  • 11.6. MEDTRONIC
  • 11.7. ABBOTT LABORATORIES
  • 11.8. STRYKER
  • 11.9. POLYGANICS
  • 11.10. NUVECTRA
  • 11.11. NEUROPACE
  • 11.12. ORTHOMED
  • 11.13. NEVRO

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 2: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 3: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 4: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 5: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: SPINAL CORD STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 7: DEEP BRAIN STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 8: VAGUS NERVE STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: SACRAL NERVE STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 10: GASTRIC ELECTRICAL STIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 11: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 12: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 13: TENS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 14: TMS DEVICES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 16: BIOMATERIALS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 17: NERVE CONDUITS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 18: NERVE PROTECTORS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: NERVE WRAPS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 20: NERVE CONNECTORS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 21: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 22: NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 23: NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 24: INTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 25: EXTERNAL NEUROSTIMULATION AND NEUROMODULATION SURGERIES MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: DIRECT NERVE REPAIR/NEURORRHAPHY MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 27: DIRECT NERVE REPAIR/NEURORRHAPHY MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 28: EPINEURAL REPAIR MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: PERINEURAL REPAIR MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 30: GROUP FASCICULAR REPAIR MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 31: NERVE GRAFTING MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 32: NERVE GRAFTING MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 33: AUTOGRAFTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 34: ALLOGRAFTS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: XENOGRAFT MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 36: STEM CELL THERAPY MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 37: NERVE REPAIR AND REGENERATION MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 38: NERVE REPAIR AND REGENERATION MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 39: NERVE REPAIR AND REGENERATION MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 40: NERVE REPAIR AND REGENERATION MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 41: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 42: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 43: NORTH AMERICA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 44: NORTH AMERICA: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 45: NORTH AMERICA: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 46: NORTH AMERICA: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 47: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 48: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: US: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 50: NEUROLOGICAL CONDITIONS IN CANADA
  • TABLE 51: CANADA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 52: EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 53: EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 54: EUROPE: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 55: EUROPE: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 56: NORTH AMERICA: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 57: EUROPE: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 58: EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 59: EUROPE: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 60: ASIA: NERVE REPAIR AND REGENERATION MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 61: ASIA: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 62: ASIA: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 63: ASIA: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 64: ASIA: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 65: ASIA: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 66: ASIA: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 67: ASIA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 68: CHINA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 69: JAPAN: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 70: INDIA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 71: ROA: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 72: ROW: NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT, 2015-2022 (USD MILLION)
  • TABLE 73: ROW: NEUROSTIMULATION AND NEUROMODULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 74: ROW: INTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 75: ROW: EXTERNAL NEUROSTIMULATION DEVICES MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 76: ROW: BIOMATERIALS MARKET, BY TYPE, 2015-2022 (USD MILLION)
  • TABLE 77: ROW: NERVE REPAIR AND REGENERATION MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
  • TABLE 78: ROW: NERVE REPAIR AND REGENERATION MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 79: GROWTH STRATEGY MATRIX, 2014-2017
  • TABLE 80: REGULATORY APPROVAL, 2014-2017
  • TABLE 81: MERGERS AND ACQUISITIONS, 2014-2017
  • TABLE 82: PRODUCT LAUNCHES, 2014-2017
  • TABLE 83: AGREEMENTS, COLLABORATION, AND PARTNERSHIPS, 2014-2017

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN: NERVE REPAIR & REGENERATION MARKET
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: NERVE REPAIR AND REGENERATION MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD BILLION)
  • FIGURE 7: NERVE REPAIR AND REGENERATION MARKET SIZE, BY APPLICATION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 8: NERVE REPAIR AND REGENERATION MARKET SIZE, BY END USER, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: NERVE REPAIR AND REGENERATION MARKET SIZE, BY REGION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 10: HIGH INCIDENCE OF NERVE INJURIES AND GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE THE MARKET GROWTH
  • FIGURE 11: NEUROSTIMULATION AND NEUROMODULATION SURGERIES TO DOMINATE THE ASIAN NERVE REPAIR AND REGENERATION MARKET IN 2017
  • FIGURE 12: ASIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 13: XENOGRAFTS WILL CONTINUE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 14: NERVE REPAIR AND REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: NEUROSTIMULATION AND NEUROMODULATION DEVICES, THE LARGEST PRODUCT SEGMENT IN THE MARKET
  • FIGURE 16: NEUROSTIMULATION AND NEUROMODULATION SURGERIES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 17: HOSPITALS & CLINICS SEGMENT TO DOMINATE THE NERVE REPAIR AND REGENERATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 18: NORTH AMERICA TO DOMINATE THE NERVE REPAIR AND REGENERATION MARKET IN 2017
  • FIGURE 19: ASIA TO REGISTER THE HIGHEST CAGR IN THE NERVE REPAIR AND REGENERATION MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: NORTH AMERICA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT
  • FIGURE 21: ASIA: NERVE REPAIR AND REGENERATION MARKET SNAPSHOT
  • FIGURE 22: NERVE REPAIR AND REGENERATION MARKET: MARKET SHARE (2016)
  • FIGURE 23: AXOGEN: COMPANY SNAPSHOT (2016)
  • FIGURE 24: BAXTER: COMPANY SNAPSHOT (2016)
  • FIGURE 25: BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2016)
  • FIGURE 26: LIVANOVA: COMPANY SNAPSHOT (2016)
  • FIGURE 27: INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2016)
  • FIGURE 28: MEDTRONIC: COMPANY SNAPSHOT (2016)
  • FIGURE 29: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 30: STRYKER: COMPANY SNAPSHOT (2016)
  • FIGURE 31: NERVO: COMPANY SNAPSHOT (2016)
Back to Top